World Stroke Academy
Edited By: Professor Michael Brainin
Online ISSN: 2051-333X
Associated Title(s): International Journal of Stroke
Recently Published Issues
Issue 3 - Essential Stroke Services
WSA Webinars and other resources
Since 2006 the WSO and the WSA have been running CME/CPD activities. You can find a series of highlight lectures recorded from previous World Stroke Congresses.
World Stroke Organization Education Meeting - Cape Town 2006
American Stroke Association bi-monthly webinar - Register here
"Delayed Cerebral Ischemia After Subarachnoid Hemorrhage" - presented by R. Loch Macdonald M.D. PhD, April 1, 2013 9 am EST.
Delayed cerebral ischemia after subarachnoid hemorrhage is a common and consequential complication that lends to an increase of morbidity and mortality. Delayed cerebral ischemia has several potential causes and clinical/imaging features that aid in its diagnosis. Treatments to prevent and ameliorate the consequences of delayed cerebral ischemia will be discussed.
1. Understand current diagnostic methods for delayed cerebral ischemia.
2. Know the most recent recommendations for medical management of delayed cerebral ischemia.
3. Know what the current rescue therapy is for delayed cerebral ischemia.
The Canadian Stroke Network Best Practices - Post Stroke Checklist as endorsed by the WSO.
Introduction to Hypertension & Stroke
Effective control of hypertension is perhaps the most important role for physicians in stroke prevention. Smoking cessation and a Mediterranean diet may rank equally or higher in importance on a population basis, but they are interventions that are carried out mostly by the people themselves. The physician is more involved in control of hypertension, and in patients with resistant hypertension, control of blood pressure is paramount. A population-based study in Sweden found that 90% of strokes occurred in patients with uncontrolled hypertension. Unfortunately, blood pressure control is poor in most countries. In the United States, blood pressures of less than half of hypertensives are adequately controlled despite recent improvements in many aspects of hypertension care, and control rates are closer to 30% in much of the world. In the Middle East and North Africa, approximately 60% of stroke is attributable to hypertension. The proportion is probably higher in sub-Saharan Africa. Recently, hypertension has been found to be the most important contributor to the worldwide burden of disease.
Click the icons below to access to the CPD/CME activity, a further reading list and a video interview with Professor Peter Langhorne.
Hypertension & Stroke Authors
The authors of the CME/CPD activity on Hypertension & Stroke
Professor David Spence has focused on prevention of stroke throughout his career. He ran a hypertension for the first 20 years, of his work, and since then pioneered the measurement of 2-dimensional carotid total plaque area. His research program focuses on measurement of atherosclerosis by ultrasound, for patient management, genetic research and for assessing effects of new therapies. Other expertise includes vitamin therapy for homocysteine, the clinical pharmacology of stroke prevention, and identification of high-risk asymptomatic carotid stenosis. He is a member of the Editorial Boards of Hypertension, ATVB and Stroke..
Professor Jaakko Tuomilehto graduated from University Turku and University Kuopio, Finland. Since 1980 Professor of Epidemiology and Public Health at the National Public Health Insitute in Helsinki since 2000 (presently retired). He has held posts as Head of the Diabetes and Genetic Epidemiology unit and visiting professorships in the US and Asian countries. Since 2011 he is Professor for Vascular Prevention at the Danube-University in Austria. He has been the principal investigator of several studies on prevention of hypertension and is currently chairing a EU funded programme on prevention and early treatment of diabetes by drug and lifestyle interventions.